You can buy or sell STOK and other stocks, options, ETFs, and crypto commission-free!
Stoke Therapeutics, Inc. Common Stock, also called Stoke Therapeutics, is a biotechnology company, which engages in the research and development of treatments for genetic diseases. Read More It offers a wide range of relevant tissues, including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
52 Week High
52 Week Low
— per share
Expected Nov 9, Pre-Market